vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and T1 Energy Inc. (TE). Click either name above to swap in a different company.

T1 Energy Inc. is the larger business by last-quarter revenue ($210.5M vs $202.1M, roughly 1.0× CORCEPT THERAPEUTICS INC). CORCEPT THERAPEUTICS INC runs the higher net margin — 12.0% vs -62.0%, a 74.0% gap on every dollar of revenue. T1 Energy Inc. produced more free cash flow last quarter ($55.0M vs $38.4M).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.

CORT vs TE — Head-to-Head

Bigger by revenue
TE
TE
1.0× larger
TE
$210.5M
$202.1M
CORT
Higher net margin
CORT
CORT
74.0% more per $
CORT
12.0%
-62.0%
TE
More free cash flow
TE
TE
$16.6M more FCF
TE
$55.0M
$38.4M
CORT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CORT
CORT
TE
TE
Revenue
$202.1M
$210.5M
Net Profit
$24.3M
$-130.6M
Gross Margin
98.7%
10.0%
Operating Margin
2.2%
-45.0%
Net Margin
12.0%
-62.0%
Revenue YoY
11.1%
Net Profit YoY
-21.0%
-375.2%
EPS (diluted)
$0.20
$-0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
TE
TE
Q4 25
$202.1M
Q3 25
$207.6M
$210.5M
Q2 25
$194.4M
$132.8M
Q1 25
$157.2M
$53.5M
Q4 24
$181.9M
Q3 24
$182.5M
$0
Q2 24
$163.8M
$0
Q1 24
$146.8M
$0
Net Profit
CORT
CORT
TE
TE
Q4 25
$24.3M
Q3 25
$19.7M
$-130.6M
Q2 25
$35.1M
$-31.9M
Q1 25
$20.5M
$-16.2M
Q4 24
$30.7M
Q3 24
$47.2M
$-27.5M
Q2 24
$35.5M
$-27.0M
Q1 24
$27.8M
$-28.5M
Gross Margin
CORT
CORT
TE
TE
Q4 25
98.7%
Q3 25
97.8%
10.0%
Q2 25
98.2%
24.7%
Q1 25
98.5%
33.3%
Q4 24
98.4%
Q3 24
98.4%
Q2 24
98.5%
Q1 24
98.3%
Operating Margin
CORT
CORT
TE
TE
Q4 25
2.2%
Q3 25
4.9%
-45.0%
Q2 25
13.7%
-22.0%
Q1 25
2.2%
-44.2%
Q4 24
13.9%
Q3 24
25.5%
Q2 24
21.7%
Q1 24
20.1%
Net Margin
CORT
CORT
TE
TE
Q4 25
12.0%
Q3 25
9.5%
-62.0%
Q2 25
18.1%
-24.0%
Q1 25
13.1%
-30.4%
Q4 24
16.9%
Q3 24
25.9%
Q2 24
21.7%
Q1 24
18.9%
EPS (diluted)
CORT
CORT
TE
TE
Q4 25
$0.20
Q3 25
$0.16
$-0.87
Q2 25
$0.29
$-0.21
Q1 25
$0.17
$-0.11
Q4 24
$0.25
Q3 24
$0.41
$-0.20
Q2 24
$0.32
$-0.19
Q1 24
$0.25
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
TE
TE
Cash + ST InvestmentsLiquidity on hand
$372.2M
$34.1M
Total DebtLower is stronger
$547.3M
Stockholders' EquityBook value
$647.8M
$96.9M
Total Assets
$836.7M
$1.4B
Debt / EquityLower = less leverage
5.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
TE
TE
Q4 25
$372.2M
Q3 25
$421.7M
$34.1M
Q2 25
$342.2M
$8.5M
Q1 25
$322.8M
$48.9M
Q4 24
$383.3M
Q3 24
$380.3M
$181.9M
Q2 24
$473.2M
$219.6M
Q1 24
$410.8M
$249.9M
Total Debt
CORT
CORT
TE
TE
Q4 25
Q3 25
$547.3M
Q2 25
$591.2M
Q1 25
$603.2M
Q4 24
Q3 24
Q2 24
Q1 24
$602.3M
Stockholders' Equity
CORT
CORT
TE
TE
Q4 25
$647.8M
Q3 25
$631.9M
$96.9M
Q2 25
$635.8M
$183.9M
Q1 25
$683.3M
$201.9M
Q4 24
$679.6M
Q3 24
$638.8M
$538.7M
Q2 24
$596.2M
$561.6M
Q1 24
$547.9M
$582.3M
Total Assets
CORT
CORT
TE
TE
Q4 25
$836.7M
Q3 25
$823.6M
$1.4B
Q2 25
$801.7M
$1.4B
Q1 25
$846.5M
$1.4B
Q4 24
$840.6M
Q3 24
$784.3M
$615.0M
Q2 24
$714.6M
$644.4M
Q1 24
$655.9M
$670.3M
Debt / Equity
CORT
CORT
TE
TE
Q4 25
Q3 25
5.65×
Q2 25
3.21×
Q1 25
2.99×
Q4 24
Q3 24
Q2 24
Q1 24
1.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
TE
TE
Operating Cash FlowLast quarter
$38.4M
$63.9M
Free Cash FlowOCF − Capex
$38.4M
$55.0M
FCF MarginFCF / Revenue
19.0%
26.1%
Capex IntensityCapex / Revenue
0.0%
4.2%
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters
$-42.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
TE
TE
Q4 25
$38.4M
Q3 25
$54.5M
$63.9M
Q2 25
$43.9M
$33.4M
Q1 25
$5.1M
$-44.8M
Q4 24
$59.3M
Q3 24
$73.8M
$-28.4M
Q2 24
$41.2M
$-28.0M
Q1 24
$23.8M
$-16.2M
Free Cash Flow
CORT
CORT
TE
TE
Q4 25
$38.4M
Q3 25
$55.0M
Q2 25
$43.9M
$10.6M
Q1 25
$5.0M
$-74.0M
Q4 24
$59.2M
Q3 24
$72.2M
$-34.0M
Q2 24
$40.8M
$-35.6M
Q1 24
$-37.7M
FCF Margin
CORT
CORT
TE
TE
Q4 25
19.0%
Q3 25
26.1%
Q2 25
22.6%
8.0%
Q1 25
3.2%
-138.4%
Q4 24
32.5%
Q3 24
39.5%
Q2 24
24.9%
Q1 24
Capex Intensity
CORT
CORT
TE
TE
Q4 25
0.0%
Q3 25
0.0%
4.2%
Q2 25
0.0%
17.2%
Q1 25
0.1%
54.5%
Q4 24
0.1%
Q3 24
0.9%
Q2 24
0.3%
Q1 24
0.0%
Cash Conversion
CORT
CORT
TE
TE
Q4 25
1.58×
Q3 25
2.77×
Q2 25
1.25×
Q1 25
0.25×
Q4 24
1.93×
Q3 24
1.56×
Q2 24
1.16×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORT
CORT

Segment breakdown not available.

TE
TE

Related Party$120.1M57%
Nonrelated Party$90.4M43%

Related Comparisons